Metropolis Healthcare: Metropolis Healthcare raises Rs 530 crore from anchor investors

The price band has been fixed in the range of Rs 877-880 per share.

Apr 02, 2019, 09.32 PM IST

Getty Images

Mumbai: Diagnostics company

Metropolis Healthcare

has allotted Rs 530.05 crore worth of shares to 26

anchor investors

at Rs 880 apiece, a day before the opening of its Rs 1,204 crore initial public offering (



The investors include, Small Cap World Fund, Neuberger Berman Emerging Market Equity Fund, Fundsmith Emerging Equities Trust Plc and First State Indian Sub Continent Fund among others.

The company is looking to sell 13,685,095 shares through the IPO.

Of these, promoter Sushil Shah will sell 6,272,335 shares, while investor CA Lotus Investments, a subsidiary of US-based private equity firm Carlyle Group will offload 7,412,760 shares.

The price band has been fixed in the range of Rs 877-880 per share.

Metropolis’ revenue from operations rose at a CAGR of 16.3 per cent to Rs 643.6 crore from FY16 to FY18, while its profits rose at a CAGR of 15.7 per cent to Rs 109.7 crore. The company is debt free.

Metropolis has presence across 19 states and a leadership position in West and South India through its network of 83 clinical laboratories, 1,473 patient touch points and 396 ARCs (assisted referral centres) in the regions.

Also Read

Metropolis Healthcare Rs 1,204 crore IPO to open on April 3

Metropolis Healthcare files IPO papers with Sebi

Inventia, Metropolis Healthcare, Xelpmoc Design get Sebi nod for IPO

Metropolis Healthcare plans Rs 100 crore expansion

Metropolis Healthcare’s Ameera Shah feels business mergers should be like relationships

Commenting feature is disabled in your country/region.


Author: Prakash Poojary

Business Analyst

Leave a Reply